Back to the main directory
Event / Equity
- Espresso | Jungheinrich | Hold | 2020 outlook withdrawn by Kepler Cheuvreux
- Espresso | Continental | Hold | Second Q1 pre-release better than first one, like consequent consensus by Kepler Cheuvreux
- Espresso | Akastor | Buy | Q1 results in line, high uncertainty for the rest of 2020 by Kepler Cheuvreux
- Espresso | Skanska | Buy | Q1: Strong beat across the board but market outlook more cautious by Kepler Cheuvreux
- Espresso | Capgemini | Buy | Organic growth of 2.0% in Q1 by Kepler Cheuvreux
- Espresso | NCC | Hold | Q1: near-term demand seen solid by Kepler Cheuvreux
- Espresso | EOS Imaging | Under Review | FY 2019 results and Q1 sales by Kepler Cheuvreux
- Espresso | UBS | Buy | Q1 first reaction by Kepler Cheuvreux
- Espresso | Novartis | Hold | Guidance reiterated: driven by Sandoz, pharma mix slightly weak by Kepler Cheuvreux
- Espresso | Cegedim | Hold | Q1 revenues a bit above estimates, not much visibility for 2020 by Kepler Cheuvreux
- Espresso | Elekta | Buy | Outlook pulled on the back of COVID-19 by Kepler Cheuvreux
- Espresso | Recticel | Buy | Q1 ahead, but April is the trough by Kepler Cheuvreux
- Espresso | Wihlborgs | Buy | Q1: Another quarter of positive net letting, but still with cautious outlook by Kepler Cheuvreux
- Espresso | Coca-Cola European Partners | Buy | Solid cost savings effort by Kepler Cheuvreux
- Espresso | Marinomed Biotech AG | Hold | Joins the race against SARS-CoV-2 by Kepler Cheuvreux
- Espresso | Cancom | Buy | Solid outlook by Kepler Cheuvreux
- Espresso | Delivery Hero | Buy | Own delivery business helps to sustain the COVID-19 pressure by Kepler Cheuvreux
- Espresso | AF Poyry | Buy | Q1 first take: below expectations on lower sales, margins more in line by Kepler Cheuvreux
- Espresso | Royal Unibrew | Buy | Q1 in line, cost savings implemented by Kepler Cheuvreux
- Santander CIB: Vidrala: Feedback from Virtual Roadshow with CFO by Santander
- Espresso | MTG | Buy | Q1 report, first impression by Kepler Cheuvreux
- Espresso | ADO Properties | Hold | ADOs takeover of Adler now complete by Kepler Cheuvreux
- Espresso | Bone Therapeutics | Hold | Secures financing of EUR11m by Kepler Cheuvreux
- Espresso | Cofinimmo | Buy | Lowering guidance slightly below our expectations by Kepler Cheuvreux
- Espresso | Corem Property Group | Hold | Good report, but mitigated by financial value changes by Kepler Cheuvreux